Open AccessBreast implant capsule‑associated squamous cell carcinoma: case report
Author(s) -
А. Д. Зикиряходжаев,
Ш. Г. Хакимова,
Е. А. Рассказова,
Э. К. Сарибекян,
Д. Ф. Омарова,
В. С. Суркова,
Г. Г. Хакимова
Publication year - 2021
Publication title -
zlokačestvennye opuholi
Language(s) - English
Resource type - Journals
eISSN - 2587-6813
pISSN - 2224-5057
DOI - 10.18027/2224-5057-2020-10-4-30-37
Subject(s) - medicine , breast cancer , radiation therapy , implant , axillary lymph node dissection , breast implant , capsule , breast carcinoma , lymph node , surgery , carcinoma , cancer , radiology , oncology , sentinel lymph node , botany , biology
Breast augmentation with the use of silicone breast implants is a routine practice for breast surgeons. Breast implant capsule‑associated squamous cell carcinoma is a rare and aggressive malignant tumor accounting for less than 0,1 % of invasive breast cancer. Currently there is no single concept of a complex therapy for such tumors due to the low incidence rate. The article describes a case of a 49‑year‑old female patient after surgical treatment of left‑sided breast implant capsule‑associated squamous cell carcinoma diagnosed in 2019. After the disease progression the patient underwent removal of the chest wall tumor with resection of ribs 3–5, allo‑and autoplasty, and left axillary lymph node dissection (ALND). In most cases, breast implant capsule‑associated squamous cell carcinoma is treated surgically but the role of adjuvant chemotherapy, radiation therapy, and endocrine therapy is still ambiguous.